Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Agent Optimization: Absorption, Distribution, Metabolism, Excretion, Dose, and Decay.

Literature DB >> 33277392

Agent Optimization: Absorption, Distribution, Metabolism, Excretion, Dose, and Decay.

Martin W Brechbiel¹.

Abstract

Entities: Chemical

Year: 2020 PMID： 33277392 PMCID： PMC8049372 DOI： 10.2967/jnumed.120.258095

Source DB: PubMed Journal: J Nucl Med ISSN： 0161-5505 Impact factor: 10.057

Keyword Cloud
References

× No keyword cloud information.

10 in total

Review 1. Antibody-targeted radiation cancer therapy.

Authors: Diane E Milenic; Erik D Brady; Martin W Brechbiel
Journal: Nat Rev Drug Discov Date: 2004-06 Impact factor: 84.694

2. Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.

Authors: Sangeeta Ray Banerjee; Catherine A Foss; Mrudula Pullambhatla; Yuchuan Wang; Senthamizhchelvan Srinivasan; Robert F Hobbs; Kwamena E Baidoo; Martin W Brechbiel; Sridhar Nimmagadda; Ronnie C Mease; George Sgouros; Martin G Pomper
Journal: J Nucl Med Date: 2015-02-26 Impact factor: 10.057

Review 3. In vivo imaging with antibodies and engineered fragments.

Authors: Amanda C Freise; Anna M Wu
Journal: Mol Immunol Date: 2015-04-28 Impact factor: 4.407

Review 4. Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors: C Andrew Boswell; Martin W Brechbiel
Journal: Nucl Med Biol Date: 2007-06-08 Impact factor: 2.408

5. Numerical comparison of iodine-based and indium-based antibody biodistributions.

Authors: Lawrence E Williams; Anna M Wu; Vania E Kenanova; Tove Olafsen; Paul J Yazaki
Journal: Cancer Biother Radiopharm Date: 2014-01-20 Impact factor: 3.099

Review 6. Aligning physics and physiology: Engineering antibodies for radionuclide delivery.

Authors: Wen-Ting K Tsai; Anna M Wu
Journal: J Labelled Comp Radiopharm Date: 2018-05-15 Impact factor: 1.921

7. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

Authors: S Hu; L Shively; A Raubitschek; M Sherman; L E Williams; J Y Wong; J E Shively; A M Wu
Journal: Cancer Res Date: 1996-07-01 Impact factor: 12.701